Steven Cohen's VRTX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 2,625 shares of Vertex Pharmaceuticals Incorporated (VRTX) worth $1.3 M, representing 0.00% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 37 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in VRTX, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2017, adding 898,089 shares. Largest reduction occurred in Q2 2016, reducing 838,700 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Vertex Pharmaceuticals Incorporated (VRTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Vertex Pharmaceuticals Incorporated (VRTX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +2,625 | New Buy | 2,625 | $496.73 |
| Q4 2023 | -85,414 | Sold Out | 0 | $0.00 |
| Q3 2023 | -161,025 | Reduce 65.34% | 85,414 | $347.74 |
| Q2 2023 | -12,061 | Reduce 4.67% | 246,439 | $351.91 |
| Q1 2023 | +147,661 | Add 133.22% | 258,500 | $315.07 |
| Q4 2022 | +3,439 | Add 3.20% | 110,839 | $288.78 |
| Q3 2022 | +107,400 | New Buy | 107,400 | $289.54 |
| Q1 2022 | -47,600 | Sold Out | 0 | $0.00 |
| Q4 2021 | +47,600 | New Buy | 47,600 | $219.60 |
| Q3 2021 | -66,500 | Sold Out | 0 | $0.00 |
| Q2 2021 | -597,473 | Reduce 89.98% | 66,500 | $201.62 |
| Q1 2021 | +440,873 | Add 197.61% | 663,973 | $214.89 |
| Q4 2020 | +92,900 | Add 71.35% | 223,100 | $236.34 |
| Q3 2020 | +130,200 | New Buy | 130,200 | $272.12 |
| Q1 2020 | -114,821 | Sold Out | 0 | $0.00 |
| Q4 2019 | -80,490 | Reduce 41.21% | 114,821 | $218.95 |
| Q3 2019 | +77,939 | Add 66.40% | 195,311 | $169.42 |
| Q2 2019 | +6,654 | Add 6.01% | 117,372 | $183.38 |
| Q1 2019 | +42,518 | Add 62.34% | 110,718 | $183.95 |
| Q4 2018 | -34,700 | Reduce 33.72% | 68,200 | $165.70 |
| Q3 2018 | -241,915 | Reduce 70.16% | 102,900 | $192.74 |
| Q2 2018 | +314,815 | Add 1049.38% | 344,815 | $169.96 |
| Q1 2018 | -679,817 | Reduce 95.77% | 30,000 | $162.97 |
| Q4 2017 | -199,413 | Reduce 21.93% | 709,817 | $149.86 |
| Q3 2017 | +898,089 | Add 8061.12% | 909,230 | $152.04 |
| Q2 2017 | -260,522 | Reduce 95.90% | 11,141 | $128.89 |
| Q1 2017 | -615,337 | Reduce 69.37% | 271,663 | $109.35 |
| Q4 2016 | +887,000 | New Buy | 887,000 | $73.67 |
| Q2 2016 | -838,700 | Sold Out | 0 | $0.00 |
| Q1 2016 | +838,700 | New Buy | 838,700 | $79.49 |
| Q4 2015 | -15,000 | Sold Out | 0 | $0.00 |
| Q3 2015 | +15,000 | New Buy | 15,000 | $104.13 |
| Q2 2015 | -29,200 | Sold Out | 0 | $0.00 |
| Q1 2015 | +12,700 | Add 76.97% | 29,200 | $117.98 |
| Q4 2014 | -426,800 | Reduce 96.28% | 16,500 | $118.79 |
| Q3 2014 | -491,400 | Reduce 52.57% | 443,300 | $112.31 |
| Q2 2014 | +934,700 | Add 0.00% | 934,700 | $94.68 |
Steven Cohen's Vertex Pharmaceuticals Incorporated Investment FAQs
Steven Cohen first purchased Vertex Pharmaceuticals Incorporated (VRTX) in Q2 2014, acquiring 934,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Vertex Pharmaceuticals Incorporated (VRTX) for 37 quarters since Q2 2014.
Steven Cohen's largest addition to Vertex Pharmaceuticals Incorporated (VRTX) was in Q2 2014, adding 934,700 shares worth $88.5 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 2,625 shares of Vertex Pharmaceuticals Incorporated (VRTX), valued at approximately $1.3 M.
As of the Q2 2026 filing, Vertex Pharmaceuticals Incorporated (VRTX) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Vertex Pharmaceuticals Incorporated (VRTX) was 934,700 shares, as reported at the end of Q2 2014.